CIK: 1276550 - Address: C/o Celgene Corporation, 86 Morris Avenue, Summit, NJ 07901
8 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

S%ret114-1-1-0816187
S%wins1007567330046

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

2/11/19 16:05
2/7/19
CELGCelgene Corp /de/DEHealthDrugPharmaceutical PreparationsLoughlin James JNJDS.d-2,04887.290-23-3740D
6/5/18 16:15
6/4/18
CELGCelgene Corp /de/DEHealthDrugPharmaceutical PreparationsLoughlin James JNJDS.d-1,40278.960-18-3336D
3/13/18 16:22
3/12/18
CELGCelgene Corp /de/DEHealthDrugPharmaceutical PreparationsLoughlin James JNJDS.d-85192.010-9-2626D
6/27/17 16:39
6/26/17
CELGCelgene Corp /de/DEHealthDrugPharmaceutical PreparationsLoughlin James JNJDS.d-2,471133.570-19-4225D
5/2/17 16:20
5/1/17
CELGCelgene Corp /de/DEHealthDrugPharmaceutical PreparationsLoughlin James JNJDS.d-1,147124.0033-9-2725D15201810-2-11-10-4
8/24/16 16:28
8/23/16
CELGCelgene Corp /de/DEHealthDrugPharmaceutical PreparationsLoughlin James JNJDS.d-3,138114.1033-28-5325D241121012-212-2-30128
2/24/16 16:56
2/22/16
CELGCelgene Corp /de/DEHealthDrugPharmaceutical PreparationsLoughlin James JNJDS-219104.1233-2-922D27-18-14-11-152-103-2-11217
8/26/14 16:21
8/22/14
CELGCelgene Corp /de/DEHealthDrugPharmaceutical PreparationsLoughlin James JNJDS.d-1,82591.2533-20-5219D1623514208862-1-11132918

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact